Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Bridoux

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2018
Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II TrialMeletios Dimopoulos, Katja Weisel, Niels W C J van de Donk, et al.
Blood Cancer Journal|January 25, 2023
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018Giovanni Palladini, Stefan Schönland, Giampaolo Merlini, et al.
American Journal of Hematology|May 4, 2023
Prognosis and long-term outcomes in type I cryoglobulinemia: A multicenter study of 168 patientsAmine Ghembaza, Gonçalo Boleto, Marin Bommelaer, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 15, 2023
C3 Glomerulopathy With Concurrent Thrombotic Microangiopathy: Clinical and Immunological FeaturesMelchior Chabannes, Marion Rabant, Carine El Sissy, et al.
JAMA|December 7, 2017
Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy: A Randomized Clinical TrialFrank Bridoux, Pierre-Louis Carron, Brigitte Pegourie, et al.
Kidney International|November 12, 2021
The characteristics of patients with kidney light chain deposition disease concurrent with light chain amyloidosisSamar M Said, Alejandro Best Rocha, Anthony M Valeri, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 31, 2022
Association between kinetic of anti-neutrophil cytoplasmic antibody (ANCA), renal survival and relapse risk in ANCA glomerulonephritisClément Samoreau, Giorgina Barbara Piccoli, Cécile Martin, et al.
American Journal of Hematology|October 24, 2025
Parameters Associated With Renal Recovery and Survival in Myeloma Patients With Acute Renal Failure to Cast NephropathyHeinz Ludwig, Meletios Athanasios Dimopoulos, Evangelos Terpos, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 7, 2024
Healthcare Resource Utilization and Cost-of-Illness in Systemic Light Chain (AL) Amyloidosis in Europe: Results From the Real-World, Retrospective EMN23 StudyArnaud Jaccard, Frank Bridoux, Wilfried Roeloffzen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 13, 2021
ANCA-Negative Pauci-immune Necrotizing Glomerulonephritis: A Case Series and a New Clinical ClassificationCharles Ronsin, Marie Georges, Agnès Chapelet-Debout, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2018
Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II TrialMeletios Dimopoulos, Katja Weisel, Niels W C J van de Donk, et al.
Blood Cancer Journal|January 25, 2023
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018Giovanni Palladini, Stefan Schönland, Giampaolo Merlini, et al.
American Journal of Hematology|May 4, 2023
Prognosis and long-term outcomes in type I cryoglobulinemia: A multicenter study of 168 patientsAmine Ghembaza, Gonçalo Boleto, Marin Bommelaer, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 15, 2023
C3 Glomerulopathy With Concurrent Thrombotic Microangiopathy: Clinical and Immunological FeaturesMelchior Chabannes, Marion Rabant, Carine El Sissy, et al.
JAMA|December 7, 2017
Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy: A Randomized Clinical TrialFrank Bridoux, Pierre-Louis Carron, Brigitte Pegourie, et al.
Kidney International|November 12, 2021
The characteristics of patients with kidney light chain deposition disease concurrent with light chain amyloidosisSamar M Said, Alejandro Best Rocha, Anthony M Valeri, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 31, 2022
Association between kinetic of anti-neutrophil cytoplasmic antibody (ANCA), renal survival and relapse risk in ANCA glomerulonephritisClément Samoreau, Giorgina Barbara Piccoli, Cécile Martin, et al.
American Journal of Hematology|October 24, 2025
Parameters Associated With Renal Recovery and Survival in Myeloma Patients With Acute Renal Failure to Cast NephropathyHeinz Ludwig, Meletios Athanasios Dimopoulos, Evangelos Terpos, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 7, 2024
Healthcare Resource Utilization and Cost-of-Illness in Systemic Light Chain (AL) Amyloidosis in Europe: Results From the Real-World, Retrospective EMN23 StudyArnaud Jaccard, Frank Bridoux, Wilfried Roeloffzen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 13, 2021
ANCA-Negative Pauci-immune Necrotizing Glomerulonephritis: A Case Series and a New Clinical ClassificationCharles Ronsin, Marie Georges, Agnès Chapelet-Debout, et al.
Pageof 17